Sara Yang Bosco Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 days, 23 hours ago
Sara Yang Bosco has an estimated net worth of at least $15.6 million*, as of April 23, 2025. They own 138,962 shares of EMR stock. They have sold 10,977 shares of EMR stock since 2021, for an estimated $1.0 million.
Sara Yang Bosco $EMR SEC Form 4 Insider Trading
Sara Yang Bosco has filed a total of 1 insider trades in $EMR since 2021. Their most recent trade was a sale of 10,977 shares, made on Nov 08, 2022. Their largest trade was a sale of 10,977 shares, made on Nov 08, 2022. We estimate that they now own 138,962 shares of $EMR, worth an estimated $14.6 million.
Insider Trading at $EMR
There have been a total of 23 insider trades reported at $EMR since 2021, with 24,400 shares purchased and 270,990 shares sold. The most active insider traders in $EMR stock have been Frank J Dellaquila, Surendralal Lanca Karsanbhai, and Surendralal Lanca Karsanbhai. The most recent trade was a sale of 20 shares reported by MARK A BLINN (None), made on Feb 12, 2025.
History of Insider Stock Trades by Sara Yang Bosco
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
EMR
|
Sale | 10,977 | Nov 08, 2022 | Nov. 10, 2022, 5:21 p.m. |
$EMR Executives and Stock Owners with Insider Trades
-
Frank J Dellaquila, Senior Exec. VP and CFO
-
Surendralal Lanca Karsanbhai, CEO and President
-
Surendralal Lanca Karsanbhai, President & CEO
-
Bell Katherine Button, Sr. VP & Chief Marketing Off.
-
Lisa Flavin, Senior VP & CCO
-
Mark J Bulanda, Exec Pres Auto Sols
-
Michael H. Train, SVP & Chief Sustain Officer
-
Nicholas J. Piazza, Senior VP & CPO
-
Ram R. Krishnan, Executive Vice Pres & COO
-
Sara Yang Bosco, Sr. VP, Secy and Gen. Counsel
-
Vidya Ramnath, Senior VP & CMO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.